Tipifarnib (C007B-281384)

Pre-clinical studies show that tipifarnib has antiproliferative effects on pancreatic cancer cell lines at clinically relevant concentrations (concentration that inhibits 50% growth [IC50] from 9.5 to 500 nmol/L). It also exhibits marked growth retardation and antiangiogenic effects in a pancreatic cancer xenograft model. Specification: 0.98 Molecular Formula: C27H22Cl2N4O Molecular Weight: 489.4 PubChem CID: 159324 Isomeric SMILES: CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/T125396-SCI_9246779ea65a26bf2df18a1bb76d91f6.pdf

UPC:

12142207

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No

WeightUOM:

LB

MPN:

T125396-5mg

CAS:

192185-72-1

Product Size:

5mg

Hazard Statement Codes:

H302:H315:H319:H335

Precautionary Statement Codes:

P261:P264:P270:P271:P280:P330:P301+P312:P302+P352:P304+P340:P305+P351+P338:P362+P364:P405:P403+P233:P501